Synonyms: (+)-benzetimide | R 16470 | Tremblex®
dexetimide is an approved drug
Compound class:
Synthetic organic
Comment: In addition to being an INN-assigned compound itself, dexetimide is one of the enantiomers of the INN-assigned racemic compound benzetimide. The other enantiomer of benzetimide is levetimide.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use ![]() |
Dexetimide is approved in Luxembourg and Netherlands (as Tremblex®) to treat neuroleptic-induced Parkinsonian extrapyramidal side-effects [1-2]. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Dexetimide is a muscarinic antagonist. |